Rafael Amado
Director/Board Member chez POSEIDA THERAPEUTICS, INC.
Fortune : 508 947 $ au 31/03/2024
Profil
Rafael G. Amado occupe actuellement le poste de Chief Medical Officer, EVP-Research & Development chez Allogene Therapeutics, Inc. Auparavant, il a été président de la recherche et du développement chez Adaptimmune Therapeutics Plc, premier vice-président chez GlaxoSmithKline Plc, directeur exécutif de l'oncologie thérapeutique chez Amgen Ltd. et professeur adjoint de clinique à l'université de Californie, Los Angeles. Rafael G. Amado a obtenu un doctorat de l'université de Séville.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2023 | 77 135 ( 0,05% ) | 344 793 $ | 31/03/2024 | |
| 01/05/2023 | 39 300 ( 0,04% ) | 125 367 $ | 31/03/2024 | |
ZAI LAB LTD.
0,00% | 04/04/2024 | 23 532 ( 0,00% ) | 38 787 $ | 31/03/2024 |
Postes actifs de Rafael Amado
| Sociétés | Poste | Début |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Director/Board Member | 13/04/2023 |
Anciens postes connus de Rafael Amado
| Sociétés | Poste | Fin |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30/12/2022 |
| ADAPTIMMUNE THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 12/08/2019 |
Adaptimmune LLC
 Adaptimmune LLC Medical/Nursing ServicesHealth Services Part of Adaptimmune Therapeutics Plc, Adaptimmune LLC is a private company that focuses on the use of T cell therapy to treat cancer and infectious disease. The company is based in Philadelphia, PA. | Chief Tech/Sci/R&D Officer | 01/07/2019 |
| GSK PLC | Corporate Officer/Principal | 01/03/2015 |
Amgen Ltd.
 Amgen Ltd. Miscellaneous Commercial ServicesCommercial Services Amgen Ltd. operates as a biotechnology firm. It engages in the research and development of human therapeutics to treat illnesses. The company was founded on March 1, 1989 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | 01/08/2008 |
Formation de Rafael Amado
| University of Seville | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| GSK PLC | Health Technology |
| POSEIDA THERAPEUTICS, INC. | Health Technology |
| ALLOGENE THERAPEUTICS, INC. | Health Technology |
| ZAI LAB LIMITED | Health Technology |
| ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Amgen Ltd.
Amgen Ltd. Miscellaneous Commercial ServicesCommercial Services Amgen Ltd. operates as a biotechnology firm. It engages in the research and development of human therapeutics to treat illnesses. The company was founded on March 1, 1989 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Adaptimmune LLC
Adaptimmune LLC Medical/Nursing ServicesHealth Services Part of Adaptimmune Therapeutics Plc, Adaptimmune LLC is a private company that focuses on the use of T cell therapy to treat cancer and infectious disease. The company is based in Philadelphia, PA. | Health Services |
